Zhao, Y., Zhou, C., Guo, B., Yang, X. & Wang, H. Pyrococcus furiosus Argonaute-mediated porcine epidemic diarrhea virus detection. Appl. Microbiol. Biotechnol. 108(1), 137. https://doi.org/10.1007/s00253-023-12919-0 (2024).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Li, Z., Ma, Z., Li, Y., Gao, S. & Xiao, S. Porcine epidemic diarrhea virus: Molecular mechanisms of attenuation and vaccines. Microb. Pathog. 149, 104553. https://doi.org/10.1016/j.micpath.2020.104553 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Sun, Y. et al. Porcine epidemic diarrhea virus in Asia: An alarming threat to the global pig industry. Infect. Genet. Evol. 70, 24–26. https://doi.org/10.1016/j.meegid.2019.02.013 (2019).ArticleÂ
PubMedÂ
Google ScholarÂ
Sekhon, S. S. et al. Porcine epidemic diarrhea (PED) infection, diagnosis and vaccination: A mini review. Toxicol. Environ. Health Sci. 8(5), 277–289. https://doi.org/10.1007/s13530-016-0287-8 (2016).ArticleÂ
PubMedÂ
Google ScholarÂ
Qin, Z. et al. The oral inactivated porcine epidemic diarrhea virus presenting in the intestine induces mucosal immunity in mice with alginate-chitosan microcapsules. Animals (Basel) 13(5), 889. https://doi.org/10.3390/ani13050889 (2023).ArticleÂ
PubMedÂ
Google ScholarÂ
Hou, Y. & Wang, Q. Emerging highly virulent porcine epidemic diarrhea virus: Molecular mechanisms of attenuation and rational design of live attenuated vaccines. Int. J. Mol. Sci. 20(21), 5478. https://doi.org/10.3390/ijms20215478 (2019).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wei, M. Z. et al. Overview of the recent advances in porcine epidemic diarrhea vaccines. Vet. J. 304, 106097. https://doi.org/10.1016/j.tvjl.2024.106097 (2024).ArticleÂ
PubMedÂ
Google ScholarÂ
Escalera, A. et al. The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity. Emerg. Microbes Infect. 13(1), 2297553. https://doi.org/10.1080/22221751.2023.2297553 (2024).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Muñoz-Gómez, M. J. et al. Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: A prospective study. J. Infect. Public Health 17(7), 102473. https://doi.org/10.1016/j.jiph.2024.102473 (2024).ArticleÂ
PubMedÂ
Google ScholarÂ
Golob, J. L., Lugogo, N., Lauring, A. S. & Lok, A. S. SARS-CoV-2 vaccines: A triumph of science and collaboration. JCI Insight 6(9), e149187. https://doi.org/10.1172/jci.insight.149187 (2021).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Sahu, L. K. & Singh, K. Cross-variant proof predictive vaccine design based on SARS-CoV-2 spike protein using immunoinformatics approach. Beni Suef Univ. J. Basic Appl. Sci. 12(1), 5. https://doi.org/10.1186/s43088-023-00341-4 (2023).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Pan, J. et al. An intranasal multivalent epitope-based nanoparticle vaccine confers broad protection against divergent influenza viruses. ACS Nano 17(14), 13474–13487. https://doi.org/10.1021/acsnano.3c01829 (2023).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Andreatta, M. et al. An automated benchmarking platform for MHC class II binding prediction methods. Bioinformatics 34(9), 1522–1528. https://doi.org/10.1093/bioinformatics/btx820 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Dhanda, S. K., Vir, P. & Raghava, G. P. Designing of interferon-gamma inducing MHC class-II binders. Biol. Direct 8, 30. https://doi.org/10.1186/1745-6150-8-30 (2013).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Dhanda, S. K., Gupta, S., Vir, P. & Raghava, G. P. Prediction of IL4 inducing peptides. Clin. Dev. Immunol. 2013, 263952. https://doi.org/10.1155/2013/263952 (2013).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Trolle, T. et al. Automated benchmarking of peptide-MHC class I binding predictions. Bioinformatics 31(13), 2174–2181. https://doi.org/10.1093/bioinformatics/btv123 (2015).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: Improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48(W1), W449–W454. https://doi.org/10.1093/nar/gkaa379 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Saha, S. & Raghava, G. P. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65(1), 40–48. https://doi.org/10.1002/prot.21078 (2006).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Buchan, D. W., Minneci, F., Nugent, T. C., Bryson, K. & Jones, D. T. Scalable web services for the PSIPRED Protein Analysis Workbench. Nucleic Acids Res. 41(Web Server issue), 349–357. https://doi.org/10.1093/nar/gkt381 (2013).ArticleÂ
Google ScholarÂ
Calis, J. J. et al. Properties of MHC class I presented peptides that enhance immunogenicity. PLoS Comput. Biol. 9(10), e1003266. https://doi.org/10.1371/journal.pcbi.1003266 (2013).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Gupta, S. et al. In silico approach for predicting toxicity of peptides and proteins. PLoSÂ One 8(9), e73957. https://doi.org/10.1371/journal.pone.0073957 (2013).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Bui, H. H., Sidney, J., Li, W., Fusseder, N. & Sette, A. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinform. 8, 361. https://doi.org/10.1186/1471-2105-8-361 (2007).ArticleÂ
CASÂ
Google ScholarÂ
Tahir Ul Qamar, M. et al. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2. Infect. Dis. Poverty 9(1), 132. https://doi.org/10.1186/s40249-020-00752-w (2020).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Cheng, J., Randall, A. Z., Sweredoski, M. J. & Baldi, P. SCRATCH: A protein structure and structural feature prediction server. Nucleic Acids Res. 33(Web Server issue), 72–76. https://doi.org/10.1093/nar/gki396 (2005).ArticleÂ
CASÂ
Google ScholarÂ
Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP vol 2—A server for in silico prediction of allergens. J. Mol. Model. 20(6), 2278. https://doi.org/10.1007/s00894-014-2278-5 (2014).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Duvaud, S. et al. Expasy, the Swiss Bioinformatics Resource Portal, as designed by its users. Nucleic Acids Res. 49(W1), W216–W227. https://doi.org/10.1093/nar/gkab225 (2021).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ikeda, M., Arai, M., Lao, D. M. & Shimizu, T. Transmembrane topology prediction methods: A re-assessment and improvement by a consensus method using a dataset of experimentally-characterized transmembrane topologies. In Silico Biol. 2(1), 19–33 (2002).PubMedÂ
Google ScholarÂ
Karypis, G. YASSPP: Better kernels and coding schemes lead to improvements in protein secondary structure prediction. Proteins 64(3), 575–586. https://doi.org/10.1002/prot.21036 (2006).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Yang, J. et al. Improved protein structure prediction using predicted interresidue orientations. Proc. Natl. Acad. Sci. USA 117(3), 1496–1503. https://doi.org/10.1073/pnas.1914677117 (2020).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Heo, L., Park, H. & Seok, C. GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Res. 41(Web Server issue), W384–W388. https://doi.org/10.1093/nar/gkt458 (2013).ArticleÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R. & Thornton, J. M. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8(4), 477–486. https://doi.org/10.1007/BF00228148 (1996).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Lovell, S. C. et al. Structure validation by Calpha geometry: Phi, psi and Cbeta deviation. Proteins 50(3), 437–450. https://doi.org/10.1002/prot.10286 (2003).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Jiménez-GarcÃa, B., Pons, C. & Fernández-Recio, J. pyDockWEB: A web server for rigid-body protein-protein docking using electrostatics and desolvation scoring. Bioinformatics 29(13), 1698–1699. https://doi.org/10.1093/bioinformatics/btt262 (2013).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Rapin, N., Lund, O., Bernaschi, M. & Castiglione, F. Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system. PLoSÂ One 5(4), e9862. https://doi.org/10.1371/journal.pone.0009862 (2010).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Grote, A. et al. JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 33(Web Server issue), W526–W531. https://doi.org/10.1093/nar/gki376 (2005).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Song, G., Li, R. & Cheng, M. Q. Safety, immunogenicity, and protective effective of inhaled COVID-19 vaccines: A systematic review and meta-analysis. J. Med. Virol. 96(4), e29625. https://doi.org/10.1002/jmv.29625 (2024).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Wang, D., Fang, L. & Xiao, S. Porcine epidemic diarrhea in China. Virus Res. 226, 7–13. https://doi.org/10.1016/j.virusres.2016.05.026 (2016).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Zhuang, H. et al. Molecular characterization and phylogenetic analysis of porcine epidemic diarrhea virus strains circulating in China from 2020 to 2021. BMC Vet. Res. 18(1), 392. https://doi.org/10.1186/s12917-022-03481-4 (2022).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
He, D. et al. Establishment and application of a multiplex RT-PCR to differentiate wild-type and vaccine strains of porcine epidemic diarrhea virus. J. Virol Methods 272, 113684. https://doi.org/10.1016/j.jviromet.2019.113684 (2019).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Yang, D. et al. Construction and immune effect evaluation of the S protein heptad repeat-based nanoparticle vaccine against porcine epidemic diarrhea virus. Virology 596, 110113. https://doi.org/10.1016/j.virol.2024.110113 (2024).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Choi, B., Kim, H., Choi, H. & Kang, S. Protein cage nanoparticles as delivery nanoplatforms. Adv. Exp. Med. Biol. 1064, 27–43. https://doi.org/10.1007/978-981-13-0445-3_2 (2018).ArticleÂ
CASÂ
PubMedÂ
Google ScholarÂ
Palombarini, F. et al. Self-assembling ferritin-dendrimer nanoparticles for targeted delivery of nucleic acids to myeloid leukemia cells. J. Nanobiotechnol. 19(1), 172. https://doi.org/10.1186/s12951-021-00921-5 (2021).ArticleÂ
CASÂ
Google ScholarÂ
Omoniyi, A. A. et al. In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches. Sci. Rep. 12(1), 8736. https://doi.org/10.1038/s41598-022-12651-1 (2022).ArticleÂ
ADSÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Wang, X. et al. Oral delivery of probiotics expressing dendritic cell-targeting peptide fused with porcine epidemic diarrhea virus COE antigen: A promising vaccine strategy against PEDV. Viruses 9(11), 312. https://doi.org/10.3390/v9110312 (2017).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Kumar, K. M. et al. Immunoinformatic exploration of a multi-epitope-based peptide vaccine candidate targeting emerging variants of SARS-CoV-2. Front. Microbiol. 14, 1251716. https://doi.org/10.3389/fmicb.2023.1251716 (2023).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Liu, B. M. et al. Key roles for phosphorylation and the coiled-coil domain in TRIM56-mediated positive regulation of TLR3-TRIF-dependent innate immunity. J. Biol. Chem. 300(5), 107249. https://doi.org/10.1016/j.jbc.2024.107249 (2024).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ
Ma, X. et al. Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses. Immunity 53(6), 1315-1330.e9. https://doi.org/10.1016/j.immuni.2020.11.015 (2020).ArticleÂ
CASÂ
PubMedÂ
PubMed CentralÂ
Google ScholarÂ